You are here: Home » Current Affairs » Coronavirus » News
Covid-19: Kerala increases oxygen production amid raging coronavirus crisis
Business Standard

'Have to ensure sustainability': Serum on pricing Covishield at Rs 600/dose

Serum, which produces the Oxford-AstraZeneca vaccine locally said that initial prices were kept very low globally as it was based on advance funding given by some countries

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

BS Web Team  |  New Delhi 



Photo: Abhishek Waghmare
The price of the vaccine is still lower than a lot of other medical treatment and essentials required to treat Covid-19 and other life-threatening diseases, says Serum

Serum Institute of India cleared the air on concerns expressed over the supposedly high market price for its Covishield vaccine, saying the comparison being done between global prices of the vaccine with India is inaccurate.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Sat, April 24 2021. 16:16 IST

RECOMMENDED FOR YOU